# Amneal Pharmaceuticals

Source: https://onco.cc/companies/amneal/  
OnCo record `amneal` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Amneal is a US generic and speciality drug maker with a growing sterile injectables business, one of the companies that stepped in as platinum chemotherapy ran short in 2023.

## Summary

Amneal Pharmaceuticals, based in Bridgewater, New Jersey, makes oral and injectable generics at plants in the United States and India and has invested in sterile injectable capacity for hospital drugs, including oncology generics. It is one of the manufacturers the FDA worked with to expand supply during the 2023 cisplatin and carboplatin shortage.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Tags: manufacturing-wave
- HQ: Bridgewater, New Jersey
- Type: pharma
- Website: https://www.amneal.com
- Ticker: AMRX

## Sources

- Official website: https://www.amneal.com

## Connected records

- technologies: [Generic oncology drug supply and shortage mitigation](https://onco.cc/technologies/generic-drug-shortage-response/), [Generic sterile injectables (the 2023 platinum shortage)](https://onco.cc/technologies/sterile-injectable-generics-manufacturing/), [Oral solid dose manufacturing (tablets and capsules)](https://onco.cc/technologies/oral-solid-dose-manufacturing/)

---
JSON: https://onco.cc/api/v1/entities/amneal.json